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Protein Identification and Characterization through Peptide Mass 
Spectrometry. Method Development for Improved Ricin and 
Botulinum Neurotoxin Analysis 
Abstract 
The illicit usage of toxic substances is increasing rapidly around the world, creating a 
need for comprehensive chemical methods for detecting and quantitating toxic agents 
that might be used in criminal activities or terror attacks. There are several toxic 
proteins that could potentially be used in bioterrorism or biocrime. For example, the 
plant toxins ricin and abrin are readily available, very toxic, and easily produced, and 
are therefore frequently involved in biocrime incidents. Another threat agent is the 
extremely poisonous botulinum neurotoxin, which is among the most toxic substances 
known. Forensic analyses of samples potentially containing these diverse and very 
toxic agents therefore require analytical methods capable of detecting trace amounts of 
the target analyte in complex mixtures. 
This thesis describes the development of new methods for peptide mass spectrometry 
that offer improved performance in forensic toxin analysis. A galactose affinity method 
was developed for the enrichment and subsequent analysis of ricin, abrin and botulinum 
neurotoxin. The method’s applicability was confirmed during a forensic investigation 
into illegal toxin preparations. Additionally, the investigations generated new 
information on the structural properties of ricin that will facilitate the forensic matching 
of samples to sources. Details of botulinum neurotoxin’s sophisticated intoxication 
mechanisms were determined by using a broad analytical approach to study the 
importance and heterogeneity of SV2C glycosylation. 
Overall, the results and procedures presented in this thesis will help to improve 
analytical capabilities relevant to the detection and prevention of biocrime and 
bioterrorism. More generally, it provides methodological guidance and useful strategies 
for researchers in peptide mass spectrometry. 
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…till Kanté, med vänsterfoten framåt, å vad bra, till skottläge för Payet, det är 
ett skott, I KRYSSET!! VILKET MÅL!! DET ÄR FULLSTÄNDIGT 
FANTASTISKT!! Det är 2-1 för Frankrike, det är konstnären och tavlan, solen, 
vinden och vattnet, hela havet fullt med dansande laxar. Det är alla trix i alla 
trollkarlars hattar genom alla tider. DIMITRI PAYET, WAOW-WAOW-
WAOW! UPP I KRYSSET! Ah de är ju inte klokt. Och matchen är slut i stort 
sett och så gör han ett sånt mål för Frankrike, oh la la… 
 
Christian Olsson, Radiosporten   
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Preface 
This thesis summarizes the research work that I have done as a postgraduate 
student working in a collaboration between the Swedish University of 
Agricultural Sciences (SLU) and the Swedish Defence Research Agency 
(FOI). As a student employed and supervised by SLU in its core plant biology 
facility the Umeå Plant Science Centre (UPSC), I have had access to a very 
productive research environment with excellent support from fellow PhD 
students, researchers and supervisors. I have also taken most of my courses 
through SLU, and received both strategic and technical support from that 
institution. 
Although I have been educated under SLU’s Faculty of Forest Sciences, my 
research tasks and objectives have been aligned with FOI’s purpose of 
conducting “research for a safer and more secure world”. FOI is an applied 
research institute working in the areas of defence and security, and the division 
for CBRN Defence and Security is located in Umeå. As part of this FOI 
facility, I have had the opportunity to work on research questions and tasks at 
the field’s frontier. In particular, working at FOI has granted me access not just 
to the toxic and regulated substances necessary for my research, but also to the 
institution’s vast research experience and extensive competences. Additionally, 
FOI’s active collaborations with other government agencies, defence research 
organisations, and academic research groups have provided excellent 
opportunities for presentations, dialogues, and educational visits. 
The primary goal of summarizing research in a thesis is to show that one 
fulfil the criteria for a PhD degree. My secondary goal was to provide 
methodological guidance and useful strategies for researchers in the field of 
peptide mass spectrometry. 
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1 Introduction 
Societal concerns about acts of biocrime and bioterrorism necessitate the 
development of improved chemical analysis capabilities to detect chemical and 
biological agents that may be used in such acts. The illicit usage of toxic 
substances has increased globally (Roxas-Duncan and Smith, 2012, Pita and 
Romero, 2014, Worbs et al., 2011), emphasizing the need for comprehensive 
analytical methods to detect and quantitate a range of toxic substances in 
diverse matrices. 
An act of bioterrorism is the deliberate release of viruses, bacteria or other 
agents of biological origin intended to cause illness or death in people, animals 
or plants, while an act of biocrime implies to kill or make ill single individuals 
or a small group of people. Biocrime is usually motivated by hate, revenge or 
monetary gains, while bioterrorists are driven by political, ideological or 
religious beliefs (Jansen et al., 2014, CDC). 
In suspected cases of biocrime or bioterrorism, analytical results (i.e. 
information on a sample’s composition) must be acquired and delivered as 
quickly as possible. If a sample contains toxic or dangerous substances, a rapid 
response involving the delivery of suitable medical treatments or other safety 
measures is obviously desirable (Moran et al., 2008). Similarly, if a sample can 
be rapidly proven safe, prompt dissemination of this information may prevent 
public alarm and avoid the need to enact costly precautionary measures. 
Two of the most important threat agents in these contexts are ricin and 
botulinum neurotoxin. Ricin is extracted from the seeds of the castor bean plant 
(Ricinus communis), and is a substance of concern due to its high toxicity and 
availability. The ricin plant is grown worldwide for the castor oil content of its 
seeds, but it is also common as an ornamental garden plant. Additionally, 
numerous recipes on the extraction and “recommended” use of the toxin are 
available on the internet. Consequently, it is frequently used in acts of biocrime 
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(Roxas-Duncan and Smith, 2012) and has become recognized as “the poor 
man’s toxic weapon”. 
Botulinum neurotoxin is extremely toxic and is considered the most lethal 
protein known to mankind. Fortunately, its illicit use is rare. Because it is 
produced by the common anaerobic spore-forming bacterium Clostridium 
botulinum, most cases of botulinum intoxication cases have been due to natural 
causes including food poisoning from badly preserved food. However, the 
extreme toxicity and global presence of C. botulinum spores has prompted the 
US Centre for Disease Control to designate the botulinum neurotoxin as one of 
the agent most likely to be used in acts of bioterrorism (Arnon et al., 2001, 
CDC). 
Methods for identifying these extremely toxic substances must be highly 
sensitive due to the small quantities that are sufficient to intoxicate an 
individual or a group of people.  Although ricin and botulinum neurotoxin are 
well known and widely studied proteins, deeper knowledge about their 
structures and mechanisms of intoxication facilitate the development of faster, 
more sensitive, more accurate, more specific, and more robust methods for 
their detection. 
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2 Background 
The general background information on proteins presented in sections 2.1-2.4 
is based on the following references in cases where no other references are 
provided: (Encyclopædia Britannica, Van Holde and Mathews, 1996, 
Campbell, 1996, Creighton, 1992, Branden and Tooze, 1999, Raven et al., 
2005). 
2.1 Protein Fundamentals 
Proteins are essential components of all living organisms. They are referred to 
as macromolecular polypeptides because they are large molecules composed of 
amino acids linked together by peptide bonds. There are about 20 different 
amino acids that occur naturally in proteins, and in a polypeptide they are 
arranged like wild strawberries on a straw. The sequence of amino acids in a 
protein is defined by the sequence of the corresponding gene in the organism’s 
genetic code. Each type of protein has a unique sequence of amino acids; this 
sequence, known as its primary structure, determines the protein’s shape and 
function. Proteins are involved in a wide array of functions within an organism, 
including metabolic reactions, DNA replication, immune responses, structural 
and mechanical functions, and molecule transportation. The photosynthetic 
systems of green plants are also based on a complex battery of proteins. 
2.2 Protein Synthesis 
In eukaryotes, the DNA sequence of a protein is transcribed inside the cell 
nucleus into messenger RNA (mRNA) and transported to the cell’s cytoplasm. 
The mRNA sequence is then translated into a peptide sequence by transfer 
RNA (tRNA) and the ribosome as illustrated in Figure 1. The finished 
polypeptide chain is then translocated into the endoplasmic reticulum (ER) and 
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subsequently into the Golgi apparatus, two sites at which the polypeptide can 
undergo various post-translational modifications to become a complete protein. 
 
Figure 1. Illustration of the principles of protein synthesis. The ribosome and tRNA translate 
mRNA into a polypeptide chain. A set of three ribonucleases (codons) in mRNA matches three 
anticodons in the tRNA, leading to the addition of a specific amino acid to the polypeptide 
sequence. 
The 20 protein-building amino acids encoded by triplet codons in the genetic 
code are displayed in Figure 2. The different sidechains determine the amino 
acid properties. These properties classify amino acids as nonpolar, polar or 
charged.  The white panel in Figure 2 shows how amino acids can be linked 
together by a peptide bond to form the polypeptide chain. 
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Figure 2. In left panels, the 20 protein-building amino acids are displayed with their sidechains 
outlined. They are grouped according to their side chain properties, and full name and three-letter 
code is presented below. The bottom right panel displays the mechanism of peptide bond 
formation linking amino acids into a polypeptide chain. Amino acids and peptides are always 
illustrated with the amino end (N-terminal) to the left and the carboxyl end (C-terminal) to the 
right. 
2.3 Protein Structures 
The polypeptide sequence is a protein’s primary structure, but interactions 
between different amino acids, their sidechains and their posttranslational 
modifications give rise to higher structures. The secondary structure is 
determined by hydrogen bonds between amino acids in the backbone chain. 
The most common secondary structures are α-helices and β-sheets. Proteins 
also have an overall tertiary structure, wherein the different secondary 
structures are arranged in specific ways. This tertiary structure, generally 
termed a protein’s fold or native conformation, can be stabilized by different 
interactions, including side-chain hydrogen and disulphide bonds. A fourth 
level of structure (quaternary) exists when several proteins, subunits, are 
arranged in a complex linked by non-covalent interactions. In such complexes, 
different subunits can have different functions, as later described for the 
botulinum neurotoxin complexes. 
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2.4 Post-Translational Modifications 
After a protein has been synthesized, its residues can be chemically modified 
by post-translational modification (PTM). These can alter the protein’s size and 
its physical and chemical properties, including stability, activity, folding and 
function. There are over 100 different PTMs, whereof phosphorylation is the 
most common (Khoury et al., 2011). Many eukaryotic proteins also get 
carbohydrate molecules (or “glycans”) attached to them in a PTM process of 
glycosylation. This is known to promote protein folding, improve stability and 
to have regulatory functions (Khoury et al., 2011). Two other very common 
modifications are peptide bond cleavage, a process in which polypeptides are 
transformed into mature proteins by removing a part of its sequence, and the 
formation of disulphide bonds between cysteine residues. 
2.5 Toxic Proteins: Structure and Mechanism of Action 
A toxin is defined as a poisonous substance produced within living cells or 
organisms (Dorland's Medical Dictonary). Toxins can be small molecules, 
peptides or proteins, and may be produced by bacteria, animals or plants. The 
structure and mechanism of the studied toxins ricin and botulinum neurotoxin 
are described below. 
2.5.1 Ricin 
Ricin is a highly toxic 60 kDa glycosylated protein produced in the seeds of the 
castor oil plant, Ricinus communis. In addition to being cultivated extensively 
for oil production (UN statistics), the plant is decorative as seen in Figure 3, 
and frequently used in gardening and public parks. Ricin is a type 2 ribosome-
inactivating protein (RIP-II), a group that also includes the toxins abrin and 
viscumin, and kills target cells by disrupting their protein synthesis. 
All RIP-II toxins are dimeric and initially produced as single polypeptide 
chains that are cleaved into two polypeptide chains (A and B) after translation. 
The B-chain functions as a lectin and has an affinity for galactose-terminated 
receptors on cell surfaces. The A chain acts as an enzymatic ribosomal 
inhibitor once incorporated into the targeted cell, interrupting protein synthesis 
and thereby killing the cell (Endo et al., 1987, Endo and Tsurugi, 1987, Lord et 
al., 1994, Lord et al., 2003). There are two different ricin isoforms, D and E, 
which differ in their B-chain sequences. Ricin E was suggested to be a hybrid 
between ricin D and the co-existing agglutinin described below (Ladin et al., 
1987). 
The toxicity of RIP-II toxins depends on their mode of administration. The 
disruption of cell machinery, the actual toxicity, is most lethal when executed 
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on vital organ cells, including those of the liver and kidney. The ricin and abrin 
dose required to kill 50% of mice (LD50) was reported to be in the range of 0.2-
10 µg/kg when injected or inhaled. Due to the tough protein environment in the 
stomach, toxicity by ingestion is about three orders of magnitude lower, with 
LD50 values of around 1-20 mg/kg. Consequently, consumption of the toxin 
content in a handful of seeds (about 5 mg each) is enough to cause significant 
toxic effects (Schep et al., 2009). Because of ricin’s high toxicity and 
availability, and its historical use in bioweapon programs (Smart, 1997), it has 
been regulated under the chemical weapons convention. As such, all 
production, storage or use of ricin must be declared to relevant authorities 
(CWC). The natural function of ricin’s toxicity is to protect the seeds from 
fungi or other microbes. To prevent toxicity towards itself, the plant uses a 
strategy of first producing a precursor toxin inside the ER. This proricin is then 
converted into an active toxin inside protein storage vacuoles via the removal 
of an N-terminal propeptide and the A-B linker peptide (Frigerio and Roberts, 
1998). 
There are multiple cultivars of the castor plant that differ in their geographic 
origin, appearance, and oil content. Unlike ricin E, ricin D has been found in 
all cultivars that have been studied to date, with an identical protein sequence 
in each case. Efforts to map ricin’s cultivar or geographic origin based on 
analyses of crude seed extraction procedures that might be used in bioterrorism 
have revealed differences in the contents of small molecules and other proteins, 
including ricin E (Despeyroux et al., 2000, Ovenden et al., 2009, Fredriksson 
et al., 2005, Stern et al., 2016). One frequently co-extracted protein is the 
related and very similar Ricinus communis agglutinin (RCA120). RCA120, 
possessing orders of magnitude lower toxicity compared to ricin, is a 
heterodimeric protein with two A- and two B-chains and an intact mass of 120 
kDa; its amino acid sequence exhibits approximately 89% identity with that of 
ricin (Kalb et al., 2015). 
  
20 
 
Figure 3. To the left, a Ricinus communis plant with its big characteristic leaves and spiky bright 
red seed capsules. The inset shows a split capsule with the embedded seeds. The top right image 
shows a handful of seeds from various ricin cultivars together with a neckless, popular to create 
from the beautiful seeds (purchased on Cuba). The bottom right image shows ricin’s dimeric 
structure, with the A-chain in red, B-chain in green, β-sheets as arrows, and α-helices as spirals. 
 
Figure 4. On the left, a coloured scanning electron microscope produced image of the Clostridium 
botulinum bacteria at a magnification of 4000 times (from Science Photo Library with 
permission). Rod shaped bacteria are in vegetative, growing state, while drumstick shaped are 
beginning to form spores, a non-reproductive tough and resistant survival state triggered by 
starvation. On the right, the structure of BoNT/A neurotoxin; the light chain is shown in red, the 
heavy chain in green, the β-sheets represented as arrows, and the α-helices as spirals. 
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2.5.2 Botulinum Neurotoxins 
The botulinum neurotoxin (BoNT) produced by Clostridium botulinum (both 
displayed in Figure 4) and a few other clostridia strains, is a family of proteins 
consisting of seven established serotypes termed A to G (BoNT/A-G) 
(Rossetto et al., 2014). This toxin causes the neuromuscular disease botulism, 
which is deadly if not treated in time. The toxin acts at the interface between 
neuronal and muscle cells, where it permanently disrupts the signal system for 
muscle contraction leading to long term paralysis. This is deadly when 
affecting vital muscles including those involved in breathing. 
There are three major forms of botulism. Foodborne botulism is caused by 
consuming food containing botulinum neurotoxin, usually from bacterial 
growth in poorly prepared home-canned food. A more rare kind is wound 
botulism, caused by toxin produced from Clostridium botulinum which has 
infected a wound. This type is mostly occurring among injection drug users 
with weakened immune system. The most common type is infant botulism, 
caused by consumption of botulinum bacteria spores. These are able to 
colonize the small intestine of infants as their intestinal microflora is not fully 
developed. Botulinum bacteria then starts to grow in the intestines and released 
neurotoxin is subsequently taken up into the circulation system. 
Lethal amounts of BoNT for adult humans are estimated to 1 µg/kg taken 
orally, 10 ng/kg inhaled, and 1 ng/kg intravenously, but there is reportedly 
some variation in LD50 between the different human-affecting serotypes (A, B, 
E, F and G) (Arnon et al., 2001).  Despite their extreme toxicity, both serotype 
A and B are successful, licensed drugs for to treatment of multiple medical and 
cosmetic conditions characterized by hyperactivity of peripheral synapses 
(Bigalke, 2013, Simpson et al., 2016). 
Like ricin, BoNTs are AB-type proteins that are synthesized as single 
polypeptide chains and post-translationally modified to form disulphide linked 
toxins with heavy and light chains (Figure 4). The light chain (LC) represents 
the enzymatically active part, and the heavy chain (HC) mediates the 
neurotoxin’s binding and uptake into neuronal cells (Rossetto et al., 2014). 
The mechanism by which BoNTs mainly interact with their gastrointestinal 
target cells resemble that of ricin. All BoNT serotypes are secreted along with 
several other proteins in quaternary complexes of various sizes that are known 
as progenitor toxin complexes (PTCs). In serotype A, B, C, D, and G, the 
neurotoxin (NT) can associate into large progenitor toxin complex, L- PTC, 
containing NT, NTNHA (non-toxic non-hemagglutinin), HA70 
(hemagglutinin, size 70 kDa), HA17 and HA33. In serotype E and F only the 
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medium-sized complex, M-PTC, can be formed containing NT and a partly 
disrupted NTNHA (115 kDa instead of 130 kDa). Serotype A can form both L- 
and M-PTC, and the assembled BoNT/A L-PTC complex is shown in Figure 5. 
These associated proteins protect the complex against degradation in the harsh 
environment of the stomach and confer multivalent sugar affinity that is 
important for its uptake by the epithelial cells of the small intestine (Gu et al., 
2012, Rummel, 2015). It was also proposed that the primary role of NTNHA is 
to protect NT from proteases and denaturation in decaying biological material 
rather than protection in the gastrointestinal tract (Rossetto et al., 2014). After 
entering the intercellular space, complexes dissociate via pH-induced 
conformational changes and released neuro-toxins proceeds to target neuronal 
cells (Lam and Jin, 2015). 
 
Figure 5. The BoNT A L-PTC complex consisting of one NT, one NTNHA, three HA70, three 
HA17 and six HA33 proteins. The six HA33 proteins have affinity for terminal galactoses and 
facilitates intestinal toxin uptake by a multivalent action. Figure adapted from (Yao et al., 2014) 
with permission. 
A major difference between BoNTs and ricin relates to the way the former 
interact with target cell molecules. BoNTs selectivity against neuronal cells is 
mediated by two different neuron-specific receptor molecules. Gangliosides in 
the synaptic cell membrane accumulate neurotoxin molecules. This enrichment 
greatly facilitates the subsequent interaction with a second receptor which then 
leads to the toxin’s uptake into small synaptic vesicles (Rossetto et al., 2014). 
The second receptor for BoNT/A is the luminal domain of synaptic vesicle 
glycoprotein 2 isoforms A-C (SV2A-C). This domain becomes extracellularly 
exposed as synaptic vesicles fuse with the synaptic membrane and release their 
contents as shown in Figure 6 (Janz and Sudhof, 1999). 
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NTNHA
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Figure 6. The left panel shows the normal release of the neurotransmitter acetylcholine to induce 
muscle contraction. The right panel shows how the neurotoxin’s LC cleaves vesicle receptors, 
disabeling acetylcholine release and hence muscle contraction. Picture from (Dickerson & Janda, 
2006) with permission. 
Recently it was shown that asparagine glycosylation in these luminal domains 
promote BoNT/A binding and uptake (Yao et al., 2016, Mahrhold et al., 2016). 
After uptake into the synaptic vesicles, the neurotoxin dissociates and the light 
chain exits the vesicle to specifically cleave proteins involved in the fusion of 
synaptic vesicles to the synaptic membrane. This prevents the release of 
acetylcholine at the neuron-muscle interface, leading to paralysis of the 
affected muscle and hence the symptoms of botulism (Rossetto et al., 2014). 
The general mechanism of this process is shown in Figure 6. 
2.6 Sample Preparation 
Sample preparation refers to the way in which a sample is processed before 
being subjected to a specific analysis. In protein studies, particularly those 
involving mass spectrometry (MS), sample preparation is a crucial step. Many 
chemicals are incompatible with MS, and sample matrix components could 
cause signal suppression or other instrumental problems. A large part of this 
thesis deals with development of sample preparation methods, so no further 
discussion of the broader field will be provided here. For more information on 
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this topic, I recommend the reviews of (Guerrier and Boschetti, 2007, Wang et 
al., 2014, Olszowy and Buszewski, 2014, Li and Franz, 2014). 
2.7 Proteolytic Digestion 
A key step when performing peptide mass spectrometry for protein 
identification and characterization is the transformation of target proteins into 
peptides, which is known as proteolytic digestion. All of the sample 
preparation methods described in the papers appended to this thesis involve 
digestion, and it was found that the quality of the results obtained depended 
strongly on the digesting enzyme’s efficiency and specificity, together with the 
digestion time. 
An analytical procedure may be performed to identify a specific protein, to 
elucidate details of its modification or structure, or (in a proteomics project, for 
example) to detect and possibly quantify multiple proteins simultaneously. 
Regardless of the objective, the transformation of target proteins into peptides 
is a critical step. If the proteolytic digestion is ineffective, the sensitivity of the 
analysis will decline steeply: in principle, an analysis in which the target 
protein is completely degraded to the desired peptides (corresponding to a 
100% yield) will be 20 times more sensitive than one in which the yield is only 
5%. Higher efficiencies can be achieved by using high quality enzyme batches 
with high purity and stability that achieve a high number of enzymatic 
reactions (cleavages) per time unit.  
Trypsin is a widely used proteolytic enzyme with well-defined target 
motifs. It cleaves with high specificity on the carboxyl side of the basic amino 
acids arginine and lysine (Vandermarliere et al., 2013). These properties make 
it an excellent tool in peptide mass spectrometry because they ensure that every 
newly formed peptide terminates with a positively charged amino acid, which 
facilitates ionisation. Moreover, its high specificity (which gives high 
reproducibility) makes digestions predictable, and also prevents bias among the 
resulting peptides because it, together with efficiency, prevent target sequences 
or amino acids from being “diluted” in terms of signal intensity. Additionally, 
trypsin specificity is almost independent of the reaction time, temperature, or 
enzyme concentration, making trypsin well suited for digestion protocol 
development. 
The kinetics of enzymatic reactions are described by the Michaelis-Menten 
(MM) equation (Figure 7), and the influence of trypsin digestion kinetics on 
proteomic coverage was recently analysed by Fonslow and co-workers 
(Fonslow et al., 2013). At low substrate concentrations ([S]), the reaction rate 
(v) has a linear relationship to [S], but as [S] increases, enzyme performance 
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increases and reaction kinetics approaches maximum rate, (Vmax). The 
importance of substrate concentration can be visualized by presenting the 
equation graphically as in Figure 7. In keeping with the predictions of the MM 
equation, higher substrate concentrations yielded faster digestion reactions in 
all of the four studies summarized in this thesis. 
 
Figure 7. The kinetics of the digestion of proteins into peptides by proteases are modelled by the 
Michaelis-Menten equation: the digestion rate (v) is a function of the substrate concentration 
([S]), the maximum reaction rate (Vmax), and the Michaelis-Menten constant (KM). The resulting 
graph clearly indicates that high substrate concentrations yield high digestion rates: as [S] 
increases, v rises towards Vmax. 
The speed of proteolytic reactions is somewhat temperature dependent: modest 
temperature increases lead to higher reaction turnover per time unit. Higher 
turnover rates enable shorter digestion protocols and hence shorter total sample 
preparation times. This is particularly desirable in the context of bioterrorism 
and biocrime analysis, where rapid responses are preferred. Shorter total 
sample preparation times also reduce the risk of introducing side-effects and 
undesired reactions, such as deamidation reactions (further described in section 
5.2 and in paper I), which are known to be time- and temperature-dependent 
(Ren et al., 2009). 
2.8 LC-MS and CE-MS Analysis of Proteins 
Mass spectrometry (MS) is very widely used in protein and peptide analysis, 
and mass spectrometric methods are under constant development. Separation 
techniques such as liquid chromatography (LC) and capillary electrophoresis 
(CE) can be used in conjunction with many different kinds of mass 
spectrometers, giving access to a great variety of analytical systems with 
different features. The extent of this field will not be covered in this thesis, but 
it has been comprehensively reviewed in several recent publications: (Aharoni 
½ Vmax
v
[S]
Vmax   
        
      
KM
v = reaction rate
[S] = substrate concentration
Vmax = maximum reaction rate
KM= The Michaelis-Menten
constant is substrate 
concentration at which the 
reaction rate is half Vmax
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and Brandizzi, 2012, Lu et al., 2008, Wei et al., 2013, Mikami et al., 2012, 
Yates et al., 2009, Wang et al., 2014). The most important characteristics of 
the CE- and LC-MS setups presented in this thesis are described in the 
experimental section and additionally in each paper. 
2.9 Protein Forensics 
In peptide mass spectrometry, target proteins are identified by analysing the 
molecular masses or amino acid sequences of their derived peptides. The 
former approach, which is known as peptide mass fingerprinting, will not be 
discussed further in this thesis but has been reviewed at length by multiple 
authors (Cottrell, 1994, Thiede et al., 2005). 
Criteria for sequence level (product ion) identification has been used since 
first suggested in the late 70’s on confirmation of animal drug residues (Sphon, 
1978). The development of increasingly powerful and capable mass 
spectrometers has been a major driving force behind criteria development 
because the use of instruments with higher resolutions and mass accuracies 
generally reduces the number of product ions that must be detected to achieve a 
given level of identification. This is exemplified by drug testing in sports, 
where the use of higher mass accuracy instruments increases the number of 
identification points achieved per product ion, allowing specified identification 
criteria to be achieved with fewer product ions (Thevis et al., 2007). 
In the context of monitoring compliance with the Chemical Weapons 
Convention, efforts to reliably identify ricin by peptide mass spectrometry have 
been complicated by the frequent co-occurrence of the closely related (but not 
regulated) protein RCA120, which is almost identical to ricin at the sequence 
level as noted previously. This sequence similarity necessitates careful peptide 
selection (Fredriksson et al., 2005). A set of peptides unique to ricin has been 
identified, and it has been suggested that the presence of ricin can be identified 
unambiguously on the basis of sequence information from at least two of these 
peptides (Kalb et al., 2015). In sports drug testing, unequivocal protein 
identification is based on both the uniqueness of the detected peptides, which 
must be demonstrated, and a total protein sequence coverage of at least 10% 
(WADA, 2010). A similar criterion has been proposed for CWC-related 
analysis because the sequence specificity of species such as ricin can change 
depending on the number of identified sequences of related species and the 
continuing expansion of protein databases. 
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3 Objectives 
The overall aim of the work presented in this thesis was to develop improved 
methods for the chemical analysis of toxins likely to be used in biocrime and 
bioterrorism. More specifically, the objective was to develop improved mass 
spectrometry methods for peptide based protein identification and 
characterization. 
 
The first study conducted along these lines sought to combine in-silico 
prediction, a thorough peptide investigation, and a broad analytical approach to 
study the extent of deamidation in ricin. An additional objective was to 
determine whether deamidation analysis could be useful in the forensic 
matching of ricin samples to sources. (Paper I) 
The second study focused on developing a chromatography-based affinity 
method for sample preparation with subsequent identification through peptide 
mass spectrometry in order to improve the capacity for detecting ricin and 
other RIP-II toxins. (Paper II) 
The third study utilized the natural affinity of BoNT L-PTC for galactosyl 
moieties and explored the possibility of applying the methods described in 
paper II to this toxin complex. An additional objective was to develop an NT-
specific method by activating the natural pH-triggered NT release mechanism 
on a column format. (Paper III) 
The final study in this work was conducted to determine whether a broad 
approach to analysing SV2C, a BoNT intoxication related protein, could reveal 
the effect of different glycosylation patterns on interactions with BoNT A at 
neuromuscular junctions. By applying a range of collision energies in MS 
analyses of different SV2C sequence mutants, we also sought to characterize 
each glycan’s structure and heterogeneity. (Paper IV). 
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4 Experimental 
This section describes the two mass spectrometry setups used in the studies 
presented in the appended papers. Practical details relating to sensitive protein 
identification through peptide analysis are also highlighted. 
4.1 Capillary Electrophoresis 
Capillary electrophoresis (CE) is a technique for separating various analytes, 
including proteins and peptides. The technique is using electric fields to 
separate different analytes based on their charges and capacity to migrate 
through an electrolyte solution under an applied electrical potential. The most 
widely used CE technique (and that used in paper I) is capillary zone 
electrophoresis (CZE), which employs narrow bore open tubular fused silica 
capillaries with lengths of 40-100 cm. These are filled with a suitable solvent 
and a small sample plug is injected, either hydrodynamically (by pressure) or 
electrokinetically (by potential). An electrical field (typically of 10-30 kV) is 
then applied across the capillary to drive separation. The CZE-MS setup 
presented in paper I used an applied potential of 350 V/cm; due to the MS 
hyphenation, separation was performed in a mixture of volatile solvents 
acetonitrile and formic acid. The analytes that migrate most rapidly through the 
capillary towards the cathode will be the smallest (i.e. those with the greatest 
mobility) and the most positively charged. Because the basis of separation by 
CZE differs from that for LC, the two techniques are complementary. 
A big advantages of using CZE rather than LC separations, especially in 
peptide analysis, is the ability to separate and detect very small peptides and 
even single amino acids, that are not retained in reversed phase LC. The most 
apparent drawback is the difficulty of automating CZE-MS setups, especially 
the reconditioning and voltage onset steps. Figure 8 illustrates the principles of 
CE and the specificities of the CZE-MS setup described in paper I. 
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Figure 8. Schematic picture of capillary electrophoresis (CE) separation setup on top. A sample 
plug is injected from the sample vial, and the separation of injected analytes is driven by the 
electrical potential between the inlet electrolyte and the grounded outlet electrolyte. Below is the 
CZE-MS sheath flow interface and applied potentials from paper I, generating a separation 
potential of 21 kV. The methanol and acid containing sheath flow stabilizes the electrospray 
function. 
4.2 Liquid Chromatography 
In liquid chromatography (LC), analytes are separated based on their 
interactions with a column’s stationary phase and the solvent (mobile phase) 
that is used. The stationary phase is generally hydrophobic and so interacts 
most strongly with non-polar compounds; this is referred to as reversed phase 
chromatography. However, hydrophilic stationary phases that interact most 
strongly with polar compounds (known as normal phase chromatography) are 
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also common, as are affinity phases that interact specifically with more 
complex chemical moieties on the analytes to be separated. The latter approach 
is discussed at greater length section 5.1 and in papers II and III. In reversed 
phase setups in general, and LC-MS setups in particular, the most frequently 
used stationary phase is C18, an alkyl bonded silica phase that interacts most 
strongly with hydrophobic analytes including peptides (Krokhin and Spicer, 
2009). 
All of the peptide-based mass spectrometry work presented in this thesis 
was performed using a C18 nano-UHPLC (ultra-high pressure LC) setup. In 
brief, this means that a mobile phase flow in the nanoliter range was used over 
a 150 mm x 75 µm analytical column packed with sub-2 µm sized C18 
particles, enabling high resolution and high sensitivity peptide separations. The 
packing material affects the LC column’s resolution: smaller particles lead to 
tighter column packing and thus better resolution. However, small particles 
also generate higher backpressures, necessitating the use of an UHPLC pump. 
The column length and diameter also affect performance because the number 
of analytes that can be separated (the plate number) is proportional to the 
column length, and the sensitivity is inversely proportional to the square of the 
column’s cross sectional area  (Rieux et al., 2011, Köcher et al., 2011). The 
setup also includes a small trap column, typically 10-20 mm long and with 
slightly larger inner diameter than the analytical column. The trap column is 
connected to the system via a flow valve, enabling it to be switched off-line. 
This allows an elevated flow rate to be used during initial sample loading. 
Samples are injected and loaded onto the trap-column using a high flow of 3% 
isocratic acetonitrile. This initial acetonitrile content increases system stability 
without lowering peptide detection ability. The main drawback of using high 
resolution and high sensitivity columns is the total analysis time. A sample-to-
sample time of around 45 minutes was necessary to permit sample trapping, the 
application of a suitable separation gradient, and column washing and 
regeneration. Still, non-targeted analysis of complex samples could gain from a 
slower increase in the LC gradient, creating much longer sample-to-sample 
times. The LC time program from paper III is visualized in Figure 9, with the 
different chromatography steps indicated. 
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Figure 9. The LC time program used in paper III. Samples were injected at time zero and 
thereafter loaded onto the trap-column using a high flow of 3% isocratic acetonitrile (B). The 
analytical column is switched in-line after 5 minutes and the peptide separating gradient goes up 
to 40% B in 20 minutes. Column washing and re-equilibration is important for reproducibility. 
This program generated a total sample to sample time of 45 minutes. 
4.3 Mass Spectrometry 
4.3.1 Electrospray Ionisation 
The field of mass spectrometry has evolved rapidly since the invention of 
electrospray ionisation, ESI, source in the 1980’s (Fenn, 2002). ESI is a soft 
ionization technique because it generates charged analytes with relatively low 
internal energies and thereby does not induce structural changes in the ionized 
products. Ionization is achieved by spraying a solution of the analytes through 
a needle-type tip (emitter) under the influence of differences in electrical 
potential between the emitter and the mass spectrometer. The resulting spray is 
known as a Taylor cone (Taylor, 1964). In positive mode ESI, the solvent is an 
acidic mobile phase (we used a water/acetonitrile gradient acidified with 
formic acid), which results in the formation of positively charged droplets at 
the tip of the Taylor cone. These droplets move towards the low potential 
(grounded) instrument, and repeatedly split into smaller and smaller sub-
droplets due to evaporation and analyte repulsion within the droplet, as 
illustrated in Figure 10. 
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Figure 10. The principle of electrospray ionisation, ESI: The Taylor cone emits multiple droplets 
towards the low potential (grounded) instrument. Due to evaporation and charge repulsion they 
repeatedly split into smaller and smaller drops, eventually creating charged analytes (peptides) 
that may enter the MS inlet. 
  
As the droplets shrink they become more highly charged, until eventually the 
embedded protonated peptides enters the gas phase (Herbert and Johnstone, 
2002). The use of nanoscale ESI increases the sensitivity of the analysis 
because the use of low flow rates reduces the size of the droplets leaving the 
spray emitter and thus promotes gas phase desorption (Abian et al., 1999). 
Peptides entering the gas phase typically carry multiple charges because their 
basic amino acids and sites - i.e. the N-terminal amine and the side-chains of 
lysine (K), arginine (R), and histidine (H) – all attract charges 
4.3.2 Mass Detection 
Two different Q-TOF mass spectrometers were used in the MS analyses 
discussed in this thesis. A Q-TOF instrument is a hybrid or tandem mass 
spectrometer that features both triple quadrupole and Time-of-Flight (TOF) 
mass analysers. The first mass analyser, the quadrupole (Q) part, acts as an 
active filter and collision cell. When operated in filter mode, settings enable 
ions with specific masses (i.e. mass-per-charge, m/z) to pass through to the 
TOF analyser while excluding others. The TOF component operates under 
near-vacuum conditions and analytes entering are given kinetic energy in the 
pusher that is inversely proportional to their m/z value The TOF then separates 
analytes based on their drift tube flight times (Mirsaleh-Kohan et al., 2008). In 
the flight tube, small ions with low m/z travel more quickly than high m/z ions. 
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The longer the flight tube, the better the separation and the resolution 
increases. The resolution can be further increased by introducing reflectors into 
the flight length, as illustrated in Figure 11. 
When operating a Q-TOF instrument in tandem mode (MS/MS), one selects 
a precursor ion and fragments it in the quadrupole part, and then analyses the 
resulting fragments (product or daughter ions) in the TOF part. Fragmentation 
is achieved by collision induced dissociation (CID). In CID, peptides are 
fragmented by collision with inert gases (N2, He or Ar); higher collision 
energies yield more fragments. 
Peptides primarily fragment along the backbone, allowing their sequence to 
be read from the fragments (Roepstorff and Fohlman, 1984, Steen and Mann, 
2004, Kinter and Sherman, 2005). When the precursors are glycosylated 
peptides, as in paper IV, the attached glycans are brittle and so fragment first. 
Fragmentation starts occurring at rather low collision energies (CE), so 
structure elucidation can be achieved through stepwise increases in the CE. As 
the CE is increased, N-glycosylated peptides are gradually stripped of all their 
glycans (except for the last asparagine-bound GlcNAc moiety) before the 
peptide backbone starts to break. 
 
 
Figure 11. Schematic overview of a Q-TOF mass spectrometer. The quadrupole part acts as an 
active mass filter and collision cell. Fragments or intact analytes entering the TOFs pusher are 
given kinetic energies and are then separated based on their difference in drift tube flight time. 
Separation can be increased by reflectors in the flight tube increasing the total flight length. The 
flight time is registered at the detector and translated into mass-per-charges, m/z. 
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In MS/MS mode, the precursor ion can be selected manually or automatically. 
In automatic data dependent acquisition, which is frequently used in 
proteomics studies, the most intense ions at each time slot are selected for 
MS/MS analysis. Depending on the desired or undesired masses that are 
present (e.g. peptides or matrix components), this selection can be tampered 
with using include or exclude m/z lists. Ions that are both included and detected 
are selected for MS/MS. In the MS/MS method development of paper III, the 
include list approach was initially tested to increase sensitivity, but did not 
provide the low detection levels that were sought. Automatic data dependent 
MS/MS analysis generally offers limited performance when dealing with low 
level samples in complex background. Sample matrix components then supress 
and mask target peptide signals, preventing any identification based on 
detectable m/z signals. In recent years, a new type of approach suitable for 
dealing with samples of this kind has evolved, taking advantage of the 
technical development of high resolution full scanning mass spectrometers, 
such as QTOF instruments. This approach, termed PRM (parallel reaction 
monitoring), was first defined in 2012 by Peterson and co-workers (Peterson et 
al., 2012) and is a targeted strategy where full product ion spectra of specific 
precursor ions are generated. As demonstrated in paper III, the instrument is set 
to alter between a set of precursor ions throughout a time segment. 
Consequently, peptides with a targeted m/z value can be collided to generate 
TOF-detectable product ions even if they are ‘hidden’ behind co-eluting matrix 
components or peptides. The co-eluting components fragment simultaneously, 
but specificity is achieved by selecting multiple specific fragment ions from the 
full scan data (Rauniyar, 2015, Schilling et al., 2015, Dupré et al., 2015). Also 
a recent comparison of different mass spectrometry setups for targeted MS/MS 
highlighted the benefits of using high resolution full scanning instruments to 
successfully combine sensitivity and specificity (Mbasu et al., 2016). 
In addition to its sensitivity, specificity, and high mass accuracy, the PRM 
method is also easily changeable. Adding or removing parent or daughter ions, 
changing time segments, or even switching to data-dependent full scan analysis 
can all be done easily on a run-to-run manner. In biocrime- and bioterrorism-
related analyses, this allows samples to be rapidly analysed for their general 
peptide content before performing a specific and sensitive toxin-targeting PRM 
analysis. The principle of PRM is illustrated in Figure 12. 
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Figure 12. Principle description of parallel reaction monitoring (PRM). Full product ion spectra 
of selected precursors are generated, offering both specificity and flexibility in daughter ion 
monitoring. 
4.4 Combining Sensitivity and Specificity 
When developing a sensitive protein identification method, all of the steps in 
the protocol must be developed accordingly. In the peptide mass spectrometry 
step, sensitivity must be combined with specificity so that the relevant 
identification criteria are satisfied. To ensure that this was achieved, the 
following approach was adopted in paper III. Starting with a relatively 
concentrated stock solution of the pure target protein, serial dilutions were 
created to give solutions with concentrations ranging from 2-3 orders of 
magnitude above the LC-MS instrument’s presumed detection limit, down to 
2-3 orders of magnitude below the limit. Samples were then denatured and 
precipitated using organic solvents, and trypsin digestion buffer was added 
after evaporation. To ensure complete digestion, all samples were digested 
with a quantity of trypsin sufficient to achieve complete digestion of the most 
concentrated sample. After terminating the reactions, equal volumes of each 
sample were injected and analysed on the LC-MS system. The results obtained 
for the most concentrated samples were then taken to represent the greatest 
possible range of tryptic peptides that could be generated from the toxin. These 
peptides were evaluated to determine their specificity and collective sequence 
coverage. The evaluation of these initial results also indicated whether it was 
possible to retrieve protein sero- and subtype information. BoNT serotypes 
differ significantly in sequence, but BoNT/A subtypes differ by only a few 
peptides (Kull et al., 2015). Although we only used BoNT subtype A1, we 
were still eager to identify peptides bearing subtype information. The results 
for the more dilute samples were then evaluated to see which peptides that 
supported highly sensitive analysis by remained identified, and which were 
gradually lost due to low signal intensities 
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5 Results and Discussion 
5.1 Natural Mechanism Based Affinity Enrichments 
In the work with recombinant SV2C proteins presented in paper IV, a specific 
constructed affinity tag was incorporated into the polypeptide sequence. The 
eight amino acid Strep-tag® II sequence (Trp-Ser-His-Pro-Gln-Phe-Glu-Lys), 
one of the most common affinity tags used in life science, generates a special 
motif with high affinity for streptavidin structures, including the developed 
Strep-Tactin® (Schmidt and Skerra, 2007). All samples used in paper IV were 
purified using this incorporated tag and the purification principle is illustrated 
in Figure 13. 
 
Figure 13. The Strep-tag® II peptide sequence exhibits affinity towards engineered streptavidin 
(Strep-Tactin®). Elution of enriched proteins are done using biotin structures, replacing bound 
proteins. 
Another approach is to make use of natural mechanisms that do not rely on 
recombinant tools, as is done in the protocol developed in paper II and applied 
in paper III. As part of their natural mechanisms of intoxication, both BoNT 
complexes and RIP-II toxins exhibit strong affinity for carbohydrate structures 
that are exposed on targeted cell surfaces. Such mechanism-linked natural 
affinities have previously been exploited in a variety of ways for different 
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proteins (Lyimo et al., 2012, Jimenez et al., 2013, Sun et al., 2005). A natural 
mechanism, developed through the selective pressure of evolution, is thereby 
adopted to its role. Although such a mechanism may be well suited to its 
function in vivo, to be useful analytically it must be successfully transferred to 
an in vitro system. Various column materials have been developed for use with 
carbohydrate binding proteins (lectins) and are commercially available. We 
routinely use these materials for preparative scale purification of castor bean 
extracts. The challenge we faced in paper II was to create a pressure-tolerant 
miniaturized column system that enabled high sample throughput, and offered 
greater sensitivity than existing alternatives. 
During the method’s development, the selected galactosyl-modified Poros® 
material, Figure 14, was found to successfully bind ricin. However, desorption 
of the bound ricin using lactose, which is a standard technique in preparative 
purifications, yielded unsatisfactory results. Lactose, galactose and similar 
structures containing a terminal β1-4-linked galactosyl moiety all exhibit 
affinity for ricin’s carbohydrate binding sites, so injecting a competitive 
amount of one of these sugars onto the column system should release the 
bound toxin. However, when developing a natural mechanism based approach, 
it is important to reflect on the mechanism’s purpose and origin. The cell 
surface-binding RIP-II toxins are not released from the glycans that they 
recognize after attachment; instead, they are taken up into the cell and 
transported between its compartments, with their two chains ultimately being 
separated inside the Golgi apparatus. Consequently, strong (and not readily 
reversible) binding to carbohydrates is beneficial for their evolved purpose, 
which may be why they are not successfully displaced from bound sugars 
using lactose. Therefore, an alternative approach was tested. Acidic conditions 
have been shown to change the three dimensional structures of ricin in parallel 
with a decrease in galactoside affinity (Frenoy, 1986), so the column was 
washed with a low pH (<3) solution  resulting in a rapid and complete ricin 
desorption. Acidic desorption was tested with a range of different lectins, 
including crude ricin, crude abrin, viscumin and peanut agglutinin (PNA). All 
lectins except PNA bound strongly to the galactosyl material, and acidic 
desorption was successful in all cases. It is likely that PNA was poorly retained 
because all of the other tested lectins have high affinities for the Galβ1-4 
structures with which the column was modified, whereas PNA has an affinity 
for Galβ1-3GalNAc structures. 
The subsequent sample analysis was favoured by the low pH desorption, as 
it only introduced the mass spectrometer compatible chemicals as TFA and 
methanol. The constructed miniaturized column based on peek tubing packed 
with galactosyl-modified Poros® material is displayed in Figure 14. 
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Conclusively, the developed affinity method resulted in a successful 
enrichment of galactosyl binding lectins. 
 
Figure 14. The miniaturized affinity columns were based on Poros® chromatography material (b), 
modified with a galactose terminated ligand (c), and packed into conventional peek tubing (a). 
After having developed and evaluated the miniaturized column setup with the 
galactosyl-modified Poros® stationary phase for RIP-II toxins, its use in the 
separation and analysis of botulinum neurotoxin was investigated (paper III).  
This was because the large progenitor complex of BoNT also has an affinity 
for terminal galactose structures through its associated HA33 proteins (Lee et 
al., 2013, Yao et al., 2014). While recent antidote experiments have indicated 
that it has a general affinity for a range of carbohydrate structures, terminal 
galactose moieties are the natural intestinal target of the large progenitor 
complex, L-PTC (Lee et al., 2015). 
Experiments using non-associated HA33 proteins and a HA complex 
verified the existence of a special multivalent binding feature of L-PTC 
complex, which is known as the velcro effect (Zopf and Roth, 1996, Arimitsu 
et al., 2008). Because non-associated HA33 proteins did not bind to the column 
material, but the HA complex (holding six HA33 subunits) and the complete L-
PTC complex did, this verified the need for a multivalent galactose binding 
process to associate L-PTC to galactosyl exposing surfaces. In paper II we 
showed that it can be difficult to exploit ricin’s full galactose affinity when 
other carbohydrates are present. The studies presented in paper III did not 
reveal any affinity problems caused by BoNTs attraction to matrix sugars. It 
seems likely that the velcro effect is enabling efficient BoNT L-PTCs affinity 
enrichment as competing sugar structures caused no significant enrichment 
problems. 
In addition to their glycan binding mechanism, BoNT progenitor complexes 
also exhibit a toxin release mechanism: an increase in pH, as follows when 
entering a host’s circulation system, induces conformational changes in 
NTNHA that release the associated neurotoxin (Gu et al., 2012, Eisele et al., 
ba
c
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2011, Matsui et al., 2014). This phenomenon was exploited in our developed 
experimental protocol, in which a high pH borate solution is injected onto the 
column bearing the bound L-PTC to release the NT from the complex (Figure 
15). Paper III describes the use of this approach for toxin detection in crude 
culture media. 
After specifically triggering NT release in this way, the remaining bound 
complex was eluted using the low pH desorption protocol presented in paper II. 
In contrast to the two-step method developed for RIP-II method, in which the 
first step was based on the toxin’s natural mechanism of action, the  BoNT 
enrichment protocol takes a three-step approach in which the first two steps 
exploit the toxin’s natural mechanism. In both protocols, the final step is a low 
pH injection to release all remaining bound proteins from the column, 
including components of the original toxin complex and any other galactosyl-
bound proteins. Overall, the affinity method developed in paper III enabled 
robust and specific enrichment of NT, resulting in highly sensitive MS 
analyses even when the toxin is present in a complex background. Moreover, 
the protocol is compatible with other protocols for enriching and identifying 
other species such as RIP-II or other galactosyl binding proteins. 
5.1.1 Affinity, Toxicity and Milk 
Several papers and reports have discussed the positive effect of administering 
milk or other solutions with a high lactose or galactose content after exposure 
to or intoxication by ricin (Nagatsuka et al., 2010, Lumor et al., 2013, Rasooly 
et al., 2012). In addition, it was concluded that pouring a lactose containing 
solution into a ricin exposed eye could prevent toxic effects (Strocchi et al., 
2005). No such protective effect is expected in cases of botulinum neurotoxin 
poisoning because multiple in vitro experiments with BoNT have demonstrated 
that the progenitor complex’s HA proteins bind strongly to various 
carbohydrates without in any way preventing intoxication in vivo (Lee et al., 
2015). 
41 
 
Figure 15. Schematic display of the progenitor complex chemistry relocated to a galactosyl 
modified chromatography material. BoNT samples are loaded at pH 6 keeping the toxin 
associated in complex form. Multivalent interactions, here illustrated by the velcro surface, 
efficiently enrich galactose binding progenitor complexes. The pH induced neurotoxin release 
mechanism is triggered by a high pH borate solution, successfully releasing complex bound 
neurotoxin. The subsequent low pH injection efficiently releases remaining complexes. Figure 
adapted from (Yao et al., 2014) with permission. 
Based on the results reported in paper III, this finding can be attributed to the 
strength of the velcro effect; the individual affinity of the HA33 proteins for 
free carbohydrates is not strong enough to overcome the complex’s strong 
multivalent binding to the precisely oriented carbohydrates displayed on the 
surfaces of the epithelial cells of the small intestine. The importance of this 
combined action was also stressed in a recent paper on the development of a 
BoNT antidote (Lee et al., 2015). The inability of lactose to suppress the toxic 
effects of botulinum neurotoxin has also prompted concerns about a potential 
bioterrorism attack on the US milk supply chain (Wein and Liu, 2005). 
Because lactose binds competitively to ricin, this toxin could not be used in 
such an attack; if poisoning by ricin or another RIP-II toxin is suspected, it 
would be advisable to give the victims milk to drink as a readily available and 
easily administered antidote. 
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5.2 Turning Proteins Into Peptides 
5.2.1 The Denature-Through-Precipitation Approach 
In the deamidation work (paper I) a short digestion time was necessary, 
because we only wished to monitor protein-level deamidation without any 
contribution from deamidation occurring during digestion. 
Deamidation is a posttranslational process that converts asparagine to 
aspartic and isoaspartic acid. This transformation alters the charge and can 
affect protein functionality and the standard model for the reaction is outlined 
in Figure 16. The mechanism and background of the deamidation study is 
further described in paper I, but by mapping its existence in ricin, we wanted to 
conclude if there were differences between different cultivars as well as 
between different preparations, and if this difference could contribute in 
forensic sample-to-source matching. 
 
Figure 16. Standard model for non-enzymatic deamidation of asparagine. The peptide backbone 
(thick line) is extended by one carbon when isoaspartic acid is formed. 
Deamidation during sample preparation steps performed at elevated 
temperatures (i.e. reduction and digestion) has been studied extensively in the 
context of proteomics research and requires special attention (Ren et al., 2009). 
Common sample preparation steps such as sulphur bridge reduction and 
subsequent alkylation of the free thiols were therefore not included. 
Additionally, we added a reference peptide that is known to have a high 
asparagine deamidation rate in the reactions as a control with which to monitor 
deamidation originating from sample preparation. A short digestion protocol 
was ultimately developed by using high quality trypsin and a denature-through-
precipitation approach, which makes the proteins readily accessible to the 
-NH3
Asparagine Aminosuccinyl
intermediate
Isoaspartic acid
Aspartic acid
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digestive enzymes. We have previously explored the use of organic solvents to 
aid proteolytic digestion of various proteins including ricin (Östin et al., 2007). 
This approach was effective, but necessitated the use of high enzyme 
concentrations because the organic solvents reduced the enzyme’s digestion 
efficiency. We subsequently introduced an evaporation step to replace the 
organic solvent with a suitable digestion buffer. This enables optimal reaction 
conditions using smaller quantities of the digestive enzyme without sacrificing 
efficiency. Using small quantities of the enzyme also reduces the risk of intact 
protein interference during the LC-MS analysis. Modifications of this 
denature-through-precipitation method were used in the sample preparation 
step prior to proteolytic digestion in paper I-IV. 
In Paper II, the desorbed fraction mainly consisted of the target toxin and 
the desorption buffer (50 mM TFA/50% methanol). Samples intended for mass 
spectrometry were precipitated by drying before the enzyme was added. No 
reduction and subsequent alkylation was needed as it was not critical either for 
the general protein identification objective, or for the quantitative digestion 
down to low attomole amounts (Fig. 4 in paper II). The protocol presented in 
paper III includes organic solvent precipitation, and the final digestion 
efficiency was carefully monitored using time-intensity plots of the desired 
peptides. The developed digestion method proved to be stable and yielded 
near-quantitative digestion (fig S-6 in paper III). As further explained in the 
peptide identification section below, the reduction and alkylation steps were 
absolutely necessary for the work reported in paper IV. The denature-through-
precipitation protocol was therefore further refined by performing three 
sequential reactions on the precipitate. First, the protein was precipitated to 
remove the protein storage matrix (which may contain detergents, salts, etc.). 
Then a reduction reaction was performed directly on the pellet, followed by an 
alkylation reaction (further described in the experimental section of paper IV). 
Finally, the pellet was subjected to enzymatic digestion. This novel protocol 
provided high yields of reduced, alkylated and enzymatically digested peptides 
within three hours, demonstrating both the accessibility of the SV2C-protein to 
the enzyme under these conditions and the effectiveness of the reaction 
sequence. Visual inspections of the vials during these steps confirmed that the 
precipitate persisted until the enzyme’s degradative action converted the 
protein into peptides. Visual clarification of precipitated solutions has 
previously been shown to indicate successful peptide production (Östin et al., 
2007). 
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5.3 Mass Spectrometry Analysis 
5.3.1 Specific Peptide Identification 
Considerable time and effort was saved during the development of mass 
spectrometric methods by performing thorough background studies on the 
target proteins and conducting comprehensive theoretical preparations before 
starting the experimental work. In particular, some important conclusions and 
workflow decisions could be made even at this preliminary stage simply by 
listing the desired peptides in a table together with brief summaries of their 
properties. In the following section I will describe this process in more detail 
and explain how these background studies influenced and guided each work. 
In paper I, we used a public available tool (Robinson and Robinson) to 
predict which amino acids in ricin might be predisposed to deamidate based on 
the protein’s sequence and tertiary structure. This yielded a list of all the 
protein’s asparagine (Asn) residues, ranked according to their predicted 
deamidation halftime (see tables 1 and 2 in paper I). As the prediction tool only 
gave theoretical probabilities for the different sequence motifs, we decided to 
map all the deamidation sites. After combining in silico and LC-MS data, we 
concluded that both an alternative enzyme (chymotrypsin) and an alternative 
separation method (CE-MS) would be needed to cover all of the asparagines in 
ricin. The use of chymotrypsin enabled mapping of motifs not accessible with 
trypsin, while CE-MS enabled detection and separation of shorter peptides than 
was possible with LC-MS. 
Some of the peptides were more interesting than others. The short peptides 
TA22 (NGSK) and TB9 (SNGK), which both contain highly ranked potential 
deamidation sites, were not accessible using the nano-LC column switching 
setup. Instead their detection required CZE separation combined with MS 
analysis; the deamidation of Asn60 in TB9 was confirmed in this way. Asn141 
in peptide TA12, the candidate identified as being most likely to undergo 
deamidation according to Table 2 of paper I, was not found to be deamidated in 
preliminary experiments. This was further confirmed using the synthetic TA12 
peptide with Asp substitution at Asn141. Careful analysis of this result 
suggests that this asparagine is stabilised by a hydrogen bond to a nearby 
threonine residue, Thr13, an effect that was not fully recognized by the 
deamidation prediction tool. The location of Asn141 at the very beginning of a 
rigid alpha helix structure provides additional stability, adding up to a stability 
disabling the proposed deamidation reaction. The position of Asn141 and the 
proposed hydrogen bond is highlighted in Figure 17. As seen in Table 2 of 
paper I, the comprehensive use of two enzymes and two separation techniques 
was necessary to recover all asparagine-containing peptides. 
45 
 
Figure 17. Highlighted on the left is the position of Asn141 at the very end of a rigid alpha helix 
structure. On the right the proposed hydrogen bond connecting Asn141 to the nearby Thr13. 
Another successful use of this peptide-level in silico preparation was in the 
glycan mapping of the BoNT/A receptor SV2C in paper IV. The final peptide 
selections may seem very straightforward since all of the results were from 
trypsin peptides. However, we were confronted with glycans of unknown sizes 
and numbers, sulphur bridges and very hydrophobic regions within the 
sequence of interest. When initially summarizing the theoretical tryptic 
peptides (Table 1), we identified several problematic issues. First, the 
glycosylation positions of highest interest, N559 and N565 (outlined in paper 
IV, and illustrated in Figure 1 therein), contained a possible sulphur bridge 
involving a cysteine (C*) located between them. It was necessary to reduce this 
bridge to detect the (NC*SFFHNK) peptide. However, this octa-peptide was 
expected to be extensively glycosylated, and some uncertainty remained as to 
whether the fully glycosylated peptide would be detectable by LC-MS or not. 
Another notable issue is that the upstream and downstream trypsin digestion 
sites are very close to the N559- and N565 glycosylation sites respectively, so 
the corresponding N-glycans could potentially affect the digestion efficiency at 
these sites. We therefore searched for glycosylated peptides resulting from 
unsuccessful cleavage at one or both sites, elongating the octa-peptide in both 
the C- and N-terminal directions. 
In the end, analysis of single and double mutants in the targeted sequence 
revealed the retention time of the octa-peptide core and the size of each glycan, 
thereby supplying the key information needed for complete glycan mapping as 
shown in paper IV. In the final analysis it was also shown that the reduced and 
alkylated short tryptic peptide bearing two large glycans was retrievable using 
our chosen LC-MS setup. Additionally, we concluded that one of the glycans 
Asn141
Thr13
Asn141
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did indeed suppress its downstream digestion; notably, this missed-cleavage 
peptide was the most suitable option for displaying the glycan complexity at 
N559 and N565. 
Table 1. Theoretical tryptic peptides from the wild type SV2C construct covering the luminal 
domain sequence of interest including the glycosylation positions N559 and N565. 
A.A. Start A.A. End M.C. Sequence 
519 533 0 (K) SC*TFEDVTSVNTYFK (N) 
534 551 0 (K) NglycoC*TFIDTVFDNTDFEPYK (F) 
552 558 0 (K) FIDSEFK (N) 
559 566 0 (K) NglycoC*SFFHNglycoK (T) 
567 579# 0 (K) TGC*QITFDDDYSAPGSAWSHPQFEK# (S) 
    
534 558 1 (K) NCTFIDTVFDNTDFEPYKFIDSEFK (N) 
552 566 1 (K) FIDSEFKNglycoC*SFFHNglycoK (T) 
559 579# 1 (K) NCSFFHNKTGC*QITFDDDYSAPGSAWSHPQFEK# (S) 
Amino acid (A.A.) numbering is according to SV2C wild-type sequence, (X) denotes up- and downstream 
amino acids, presumed N-glycosylated asparagines are in bold, C*=carbamidomethylated cysteine, #residues in 
italic are part of the C-terminally fused Strep-tag® II sequence and not included in the A.A. numbering.  
5.3.2 Protein Identification 
As described in the experimental section, sensitive identification of target 
proteins requires the selection of peptides that can satisfy low level detection 
demands and the desired identification criteria, which can include subtype-, 
serotype- or cultivar-specific sequences. 
In paper II, ricin peptides were chosen for maximum sensitivity while 
retaining an emphasis on specificity. The selected peptides needed to be unique 
for ricin and abrin sequences respectively, because these proteins exhibit 
extensive sequence similarities with their respective agglutinins. Consequently, 
the peptide showing the strongest response in the analysed mixture was 
common to both ricin and its agglutinin (figure 4, paper II). Its dual origin 
made this peptide unsuitable as an explicit ricin identifier, although it is still 
worth monitoring in forensic sample analysis because its presence is a sensitive 
general indicator of castor bean preparations. After selecting appropriate 
peptides, an high resolution accurate mass-based LC-MS approach was 
developed in which identification is supported by data on both the retention 
times and masses of reference sample peptides. Quantification of ricin was 
made against reference digests of ricin standards. For RIP-II toxins not 
available as quantitative reference standards a “top 3 quantification” approach 
was employed using the summed response of three high response peptides in 
the ricin reference digests as standards (Silva et al., 2006, Bygdell, 2013). 
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In paper III the most sensitive BoNT/A1 peptides specific for the parent 
protein were selected based on the results obtained using the dilution procedure 
described in the preceding sections, and the subtype information presented by 
these peptides was annotated. Because the mass spectrometric technique used 
in this case was PRM, data on the peptides’ chromatographic distributions 
were also considered. The selected peptides originated from both BoNT/A1 
chains, as shown in Table 2 below. Additionally, subtype indication could be 
extracted from this set of peptides because different subtypes of the toxin 
would present different subsets of these peptides. However, it should be noted 
that the development of a procedure capable of verified rather than indicative 
subtyping would require the development of tailored MS methods for each 
targeted subtype because the behaviour of individual peptides is difficult to 
predict. 
Table 2. Selected PRM peptides from BoNT/A1listed according to their elution order in LC-MS. 
Peptide Amino Acid1 Chain Sequence Present in Subtypes2 
1 721-729 HC VNTQIDLIR A1, A2, A3, A5 and A6 
2 232-241 LC LYGIAINPNR A1-A3, A5-A8 
3 273-283 HC FIDSLQENEFR A1, A2, A5-A8 
4 344-356 LC MoxLTEIYTEDNFVK A1, A5-A8 
5 1141-1156 HC GSVMoxTTNIYLNSSLYR A1 
6 566-581 HC IALTNSVNEALLNPSR A1 and A8 
7 582-592 HC VYTFFSSDYVK A1, A6*, A7* and A8 
8 382-393 LC VNYTIYDGFNLR A1, A5*, A6 and A7* 
IS Leu-Enk - YGGFL - 
1Amino acid sequence and residue numbering from strain Hall A1 (ATCC 3502). 2Subtype comparison is 
according to previously published alignments (Kull et al., 2015). *indicates identical sequences but the correct 
upstream trypsin motif (R or K) is missing. Mox=oxidized methionine. IS= internal standard  
5.3.3 Glycosylation Screening 
In paper IV, a collision energy alteration approach was used to solve the glycan 
structure puzzle. The use of high collision energies generated specific 
glycopeptide fragments and extracted ion chromatograms of these fragments, 
such as HexNAc 204.1 m/z (Conboy and Henion, 1992), indicated 
glycopeptide retention times as shown in Figure 18. Increasing the collision 
energy in a stepwise fashion made it possible to identify the glycans associated 
with a given peptide, and the intact glycopeptide could then be selected for 
specific LC-MS/MS analysis. In summary, this collision energy stepping 
approach fully resolved the details of SV2C’s glycan structures, as shown in 
Figure 5 and Figure 6 in paper IV. 
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Figure 18. Total ion chromatogram and extracted ion chromatogram (204.1 m/z) from high 
collision energy screening for glycopeptides in a SV2C N565Q mutant sample. Four distinct 
peaks indicating the presence of glycopeptides. In subsequent analysis peak 1 and peak 2 were 
confirmed as glycosylated peptides from the IgG1-part of the construct, whereas peak 3 was 
confirmed as the N559-A579 peptide glycosylated on N559, and peak 4 was the N534-K551 
peptide, glycosylated on N534. The two latter from the luminal domain as outlined in Table 1.     
5.4 Method Performance Evaluation 
The methods developed in papers II and III were evaluated in two different 
ways. In paper II, the affinity method was developed and then applied to toxin 
identification in various sample matrixes. This called for two types of 
evaluations: evaluations of the affinity column’s general capacity to attract 
galactose binding lectins, and evaluations of matrix effects on the system. The 
first series of evaluations was performed using pure and crude RIP-II 
preparations, and revealed that the system was capable of high capacity, 
throughput and sensitivity while retaining galactose specificity. The second 
series of evaluations was performed by calculating recoveries from a set of 
different matrices, and revealed the complete method to be matrix-tolerant, 
RIP-II-comprehensive, and compatible with both enzymatic processing and 
MS. Special attention should though be made regarding the matrix content, as 
the affinity could be suppressed by matrix present galactose or similar 
carbohydrates. Additionally, as the method enrich other galactose binding 
proteins besides RIP-IIs, this has to be considered in the subsequent digestion 
and LC-MS steps. 
In paper III we applied the developed and validated method to a botulinum 
neurotoxin. Method evaluation was performed with the pure toxin complex and 
a spiked bacterial growth matrix. The pure toxin complex was used for the 
initial proof of concept experiments, while the method’s linearity and 
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sensitivity were tested using the spiked bacterial growth matrix. In addition to 
the strengths inherited from paper II, the experiments with BoNT/A samples 
revealed the method to be NT-specific, sensitive, quantitative in the tested 
matrix, and amenable to parallelization with the previously developed RIP-II 
approach. One identified drawback in analysing BoNT is the method’s 
specificity for galactose binding complex’s, which discriminates against non-
L-PTC containing sub- and serotypes, including the human toxic E serotype 
(Rossetto et al., 2014). 
5.5 Applications 
The different methods developed in this work were shown to be useful in 
several contexts. 
The development of rapid and effective enzymatic digestion protocols to 
reduce sample preparation times was initiated by a requirement for rapid 
responses to alleged illegal use of toxins (Östin et al., 2007). Later experiments 
including the removal organic solvent before digestion significantly improved 
the protocol’s effectiveness because it allowed samples to be digested at high 
concentrations (as precipitates) using a low volume reaction mixture in the 
absence of organic solvents (Bergström et al., 2007). In paper I a high kinetic 
rate was achieved through the precipitation approach, enabling a short protocol 
to minimize peptide level deamidations. In papers II and III, the use of the 
developed method helped to ensure that the new protocols could be performed 
rapidly while still achieving complete protein digestion. As a proof of concept, 
the denaturation-through-precipitation protocol was successfully used for 
efficient and rapid digestion of the SV2C proteins in paper IV. Although in this 
case a short response time was not strictly required, the 1 h digestion time 
reduced the total time needed for sample analysis, and allowed useful results to 
be generated more quickly than would otherwise have been possible. The 
benefits of handling the target protein in pellet form were further highlighted 
by the finding that the pellets underwent efficient reduction and alkylation 
reactions in low volume reactions. 
The complete RIP-II toxin identification method was applied to samples 
from a forensic investigation into illegal production and possession of toxins. 
As described in paper II, a 32-year old man was suspected of handling toxins, 
and samples found at his apartment were submitted for analysis at FOI (Figure 
18). 
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Figure 19. Various chemicals found at the scene (left) and samples analysed regarding illegal 
production and possession of toxins (right). Photo: FOI and Swedish Police (with permission). 
The method was applied to low volume samples (10 µL) and both non-retained 
and low pH desorbed fractions were analysed using LC-MS. Peptides from 
ricin, RCA120, abrin and its corresponding agglutinin were all indicated in the 
full scan analysis (fig 5 in paper II). Diagnostic ricin biomarkers identified in 
the non-retained fractions further indicated ricin content. For unambiguous 
toxin identification, samples were reanalysed using LC-MS/MS together with 
ricin and abrin reference digests. Retention times, m/z measurements, and 
product ion spectra matched the reference material, providing conclusive 
evidence of ricin and abrin content. Finally, the method’s capacity for 
quantitation was exploited to determine the toxin concentrations in the 
samples. 
The widespread demand for ricin analysis capabilities, together with the 
diversity of techniques and reference materials used, prompted the adoption of 
a collaborative approach to develop reference materials and organize an 
international proficiency test for ricin and RCA120 analysis (Worbs et al., 
2015b). During the proficiency test, the developed RIP-II toxin identification 
method was applied to the analysis of nine blinded samples potentially 
containing ricin and/or RCA120 of unknown concentrations. Sample matrixes 
were of high protein content, including a meat extract, organic fertilizer (solid 
sample) and milk, and were all intended to mimic real sample scenarios. The 
successful detection of ricin and RCA120 at all spiking levels and in all 
matrixes except the intermediate level of ricin in the milk matrix, highlighted 
some important features of the method. Specifically, it was found that if the 
sample’s lactose content is high, lectin binding is suppressed and so RIP-II 
detection becomes impossible. However, the method proved to be viable for all 
of the other tested matrices, suitable for RIP-II detection, and less costly than 
alternative immunoaffinity methods (Kalb et al., 2015). 
In addition, a proficiency test was also organized regarding botulinum 
neurotoxin analysis (Worbs et al., 2015a). During the characterization of the 
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reference material for this test (Weisemann et al., 2015), the denaturation-
through-precipitation protocol was applied before enzymatic digestion and 
sequence-confirming mass spectrometric analysis of four different BoNT 
serotypes. As seen in Table 3, the digestion was successful, yielding almost 
50% peptide coverage for serotypes A, B and E. However, high BSA levels 
reduced the coverage achieved for serotype F peptides (Weisemann et al., 
2015). 
Table 3. Summary of LC-MS/MS results on the four characterized BoNT reference samples.  
Sample Number of peptides 
identified (of total) 
Identified peptides 
from heavy chain  
Identified peptides 
from light chain 
BoNT/A 68 (48%) 39 29 
BoNT/B 74 (47%) 44 30 
BoNT/E 64 (50%) 48 16 
BoNT/F 43 (33%) 30 13 
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6 Conclusions 
The aim of this thesis was to improve society’s capacity to deal with threats 
from biocriminal and terrorist activities, involving toxins such as ricin and 
botulinum neurotoxin. The objective was to develop novel analytical methods 
with improved performance, thereby providing tools for forensic toxin 
analysis. 
Paper I describes studies on the structural details of ricin deamidation. The 
developed analytical procedures and tools enabled mapping of all the 
deamidation sites in ricin. It was also shown that ricin’s previously reported 
isoelectric diversity is related to its level of deamidation, which may be useful 
in overcoming the forensic attribution challenge of matching a sample to a 
specific source. The outlined methodology should be applicable in other 
protein characterisation studies and the method’s potential use in forensic 
profiling could be useful in forensic studies of other proteins. 
The objective in paper II was to exploit galactose affinity for the trace 
enrichment of ricin and its RIP-II analogues. A successful RIP-II enrichment 
method utilizing the toxin’s natural toxic mechanism was developed based on a 
galactosyl modified material. The LC-MS protocol was developed for use with 
the resulting enriched samples that enables sensitive detection of ricin 
preparations and unambiguous ricin and abrin identification. The method’s 
applicability in investigations into bioterrorism and biocrime was confirmed 
during a forensic investigation of a “home-made” toxin preparation. 
The developed galactosyl affinity material was then successfully used for 
BoNT enrichment in paper III. BoNT L-PTC’s natural galactosyl binding 
capacity, and the pH-triggered NT release mechanism were successfully 
transferred to the column format, resulting in NT-specific enrichment. 
Analyses of samples related to bioterrorism and biocrime incidents must be 
conducted quickly and accurately. The newly developed affinity methods 
satisfy these criteria: they are highly sensitive for the RIP-II toxin and BoNT, 
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and have high throughputs in the affinity step. Even if analysed samples are 
found to be from hoax letters or of non-toxic content, it is important to retrieve 
general sample knowledge. In this setup, that is achieved by analysing non-
retained fractions. 
In paper IV, a broad analytical approach revealed the importance of SV2C 
glycosylation for BoNT/A interaction at the neuron-muscle interface. Mass 
spectrometric analysis of various SV2C sequence mutants revealed their glycan 
heterogeneity. The results obtained provided an improved understanding of the 
interaction between BoNT/A and its receptor. 
The overall objective for all four papers was to develop peptide mass 
spectrometry methods for protein identification and characterization. This 
objective was achieved by the development of four distinct fit-for-purpose 
methods based on new approaches to both sample preparation and mass 
spectrometry analysis. 
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7 Future Perspectives 
The results presented in this thesis highlight some new ideas and potentially 
fruitful topics for future investigation. 
First, while the deamidation data presented in paper I suggest that 
deamidation patterns could be useful in sample matching, more thorough 
investigations will be needed to determine whether such an approach is 
genuinely viable. It is possible that the seeds’ origin (cultivar), age (maturity) 
and storage conditions all affect the extent of deamidation, and that sample 
matching based on deamidation might be limited. 
Second, when analysing suspicious samples, the affinity method presented 
herein does not perform well when small quantities of the target substance are 
present together with a strongly galactosyl binding background. Further 
investigations will be needed to determine at which levels the target substance 
can be reliably detected, and whether it is the affinity method or the MS 
analysis that is limiting. The RIP-II method and the BoNT approach should 
also be integrated and the expanded three step approach evaluated to verify that 
the high pH-induced release of BoNT does not affect galactosyl bound ricin. 
The analysis of BoNT samples could be further expanded to clarify the 
proposed benefits of the velcro effect in various matrixes, and the complete 
method including the MS identification could be developed and refined to 
achieve serotype and subtype resolution. 
Finally, while the results presented in paper IV on the glycosylation of 
SV2C and its influence on interactions with BoNT are interesting, more studies 
on native proteins are needed. Interaction studies with glycosylated SV2s have 
been performed, but there has been no comprehensive glycan mapping of 
native SV2C combined with interaction studies. Such an investigation would 
be required to draw definitive conclusions regarding the role of glycosylation 
and glycan structure. 
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Acknowledgements 
Först några efterord 
 
Sådär ja.  
Avhandlingen är klar och man närmar sig ett forskarkörkort. Ja det är i alla fall 
så jag tänker mig att en doktorsexamen bäst beskrivs för den som inte är i 
branschen. I likhet med ett körkort så behöver man öva, läsa på en hel del, och 
få respons och support på vägen fram. I båda fall testas man teoretiskt såväl 
som praktiskt: teoriprov följt av uppkörning, avhandling följt av disputation.  
Vad innebär ett forskarkort då? Förutom att man utbildats, övat, och 
förhoppningsvis blivit en både bättre och mer erfaren forskare, så får man 
också ett intyg på att man kan sin sak. Precis som att man genom körkortet 
erkänns som förare, redan på papperet så att säga, på samma sätt fungerar även 
en doktorsexamen. Kan man då forska utan forskarkort? Självklart. Själv har 
jag gjort det i ett bra tag innan jag bestämde mig för att försöka ta 
forskarkortet. Här kanske jämförelsen med bilkörkortet haltar något. Mer likt 
ett förarbevis på snöskoter i det fallet. Inget måste (i alla fall om man är 
tillräckligt gammal…), utan själva utövandet ger färdigheten. En annan bra 
jämförelse är ett motorsågskörkort. Jo, det finns faktiskt. Men det kortet har jag 
kvar att ta. Men det kommer. 
Åter till själva avhandlingen. Under arbetets gång har jag insett att jag nog 
är en hyfsad problemlösare. Kanske riktigt bra i vissa stunder. Men sämre på 
att skriva ner resultat. Det lär visst finnas de som har strukturen för en text klar 
för sig redan innan de börjat skriva. Själv tillhör jag är mer de tvångsmässiga 
knådarna. Ner med texten, baka om, flytta, ta bort och lägg till. Flytta om igen, 
få respons av andra, baka om på ett annat sätt. Ett hårt arbete helt enkelt. Men 
”jämnen dra”, ni som vet vad det betyder, och till slut är jag något på spåret. 
Och till slut så sitter den där. En bra text helt enkelt. Jag vet dock inte om jag 
hann ända dit med kappan. Men ”fit-for-purpose” funkar förhoppningsvis på 
kappan också. 
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Jag hade tidigt i skrivandet en målsättning att kappan skulle vara användbar 
på längre sikt. Med bra tips och rekommendationer på peptidanalysernas 
snåriga väg fram. Hm, väldigt naivt tänkt där, Tomas. Vad jag har förstått så 
blir inte många avhandlingar speciellt vältummade (förutom acknowledgement 
då, den delen läser väl alla) eller ens öppnade efter att de blivit klara. Men jag 
tänkte att försöker säkra upp detta på mitt eget sätt. Och det redan på sidan 4 
som ni kanske sett. Så om ni i framtiden inte kommer att öppna denna 
avhandling av vetenskapliga anledningar, så kan ni i alla fall göra det när ni 
sitter och klurar på hur det egentligen var med sporthändelserna där under 
mitten av 2016. Hur gick det i fotbolls-EM? Och hur gick det för oss under OS 
i Rio? (Ja, att skriva avhandling samtidigt som dessa stora sportevent har satt 
väldigt tydliga spår). 
Börja så här då: Ta ner denna avhandling från hyllan och bläddra upp sidan 
4. Läs radiosportens okrönte referatkonung Christian Olssons referat av 
fransmannen Didier Payets kanonmål och njut av bilderna som spelas upp 
framför dig. Detta otroligt snygga mål, men framför allt den ohämmade glädje 
som Payet visade upp, kommer i alla fall för mig att vara bilden av fotbolls EM 
2016. Den där glädjen smittade verkligen av sig, ända ner i TV-soffan (jodå, 
klart att EM prioriterades). Och ett antal gånger under mina skrivande stunder 
tillsammans med radiosporten har jag haft möjlighet att återuppleva, glädjas 
och uppmuntras av, det där målet igen. Tack min vän i etern, Christian Olsson. 
För övrigt så vanns EM av Portugal efter en prestation av Eder (här 
återkommer nyttan igen; vad hette han nu, han som avgjorde finalen…) trots 
att Alfreds favorit Cristiano Ronaldo utgick tidigt ur finalen. Skyttekung blev 
Antoine Griezmann på 6 mål. Och Zlatan avslutade sin landslagskarriär med en 
förlust, men sa i en av intervjuerna; I’m only warming up! Och 34-åringen har 
vid detta verks pressläggning levererat med råge i Manchester United och leder 
skytteligan. 
Och hur var det med OS då? Sara Sjöström höll. Många andra favoriter föll. 
Ja nästan alla topptippade svenska deltagare. Men damfotbollen levererade ett 
silver, Jenny Rissveds på sin mountainbike levererade ett guld. Och en del 
stora internationella namn levererade: Bolt vann tre guld. Phelps fem. Och 
förvånande så blev Michael Jonsson av med sitt världsrekord på 400m till en 
Sydafrikan vid namn van Niekerk. Fotbollsmässigt bjöds det på frisparksgodis 
av Neymar som dessutom satte avgörande straffen för ett efterlängtat 
brasilianskt OS-guld i fotboll.  
World Cup i hockey spelas ju också i slutfasen av detta arbete. Tyvärr blir 
det svårt att återge på något trovärdigt sätt då det börjar efter 
”pressläggningen” och avslutas innan disputationen. Och gissa resultat har inte 
varit min styrka i år (referens: EM tipset 2016). Men Canada känns troliga i en 
67 
finalserie. Och hjärtat säger mot Sverige. Och med Henke L i toppform och 
Loui Eriksson i formation med Sedinarna kan det hända. Men förnuftet säger 
förlust i semin mot just Canada. Loui blir bäste poängplockare i Sverige. Håll 
förresten ett öga på Pavel Datsiuk, den ynglingen kommer att leverera. 
På tal om Henrik Lundqvist, så kanske vi ska åka och kolla på Rangers 
snart, Alfred. Innan han funderar på att trappa ner. Men det verkar som om han 
är väldigt hungrig på en Stanley Cup seger, så han kanske är med i några år till 
i alla fall. Men i år spelar ju fortfarande min favorit #68 Jagr i ligan. Hm, jag 
tror jag tar och kollar upp spelschemat redan nu. 
Nej, nog surrat om sport nu.  
 
Över till några varma tack istället: 
 
Tack alla härliga superkollegor på jobbet! (utan inbördes ordning)  
Håkan (du fick ändå stå först, kom ihåg det!), korridorens glädjespridare. 
På ditt sätt. En skön blandning av Kramer, Per Elofsson och en nördig forskare. 
När ska jag komma ikapp dig i spåret egentligen? Du är trots allt 50 snart.. Ska 
du med till Sälen i mars förresten? Du har fina vasaloppstider kvar i kroppen. 
Jag vågar ju knappt åka rullskidor med dig längre. Roger, dina bilars underhåll 
underhåller. Inget ont menat, vi skrattar inte åt dig. Snarare med… Men nu är 
det väl lugnt på den fronten ett tag. Och hoppas att det blir ordning på foten 
snart, så att vi kan köra några trailpass igen. Karin; en klippa i mycket som 
alltid levererar. Och trevlig att jobba med såklart. Johanna, glad och positiv, 
oavsett om det gäller jobb eller fritid. Den enda av här nämnda som också 
kollar golf på småtimmarna. Kanske jag kan hålla undan för dig på golfbanan, 
för när det gäller fallhöjdshöjdmeter är jag nog chanslös. Petrus och Tobias, ni 
har verkligen hamnat rätt. Kul att ni kom med på båten. Stänger ni festen?  
Lars H, pålitlighet och kunnande så det blir över. Och med ett riktigt 
lövenhjärta! Daniel och Jenny, två friska projektledarfläktar. Jag tycker ni 
bidrar till gruppen på ett imponerande sätt. Linda, håller ordning på fler och 
fler lösa trådar och gör det förträffligt. Anders, du har alltid tid över. Och bra 
svar på det mesta där i din skrubb. Det var ju vi som knäckte fram den där A-B 
peptiden på ricin en gång i tiden. Du hade tänkt rätt men räknat fel. Sedan 
hittade jag den och vi fick till ett snyggt MS/MS. Och ricinfällningarna som 
klarnade. Där klarnade ju mycket av det som är grunden i dessa pek; fällning 
och effektiv klyvning. Sten-Åke. Vi är rätt lika du och jag. Gillar 
problemlösningar. Kanske lite för noggranna ibland. Sådant tar sin tid. Men vi 
är måna om instrumenten. Det ska vara rent och snyggt, även på insidan så att 
säga. Men oj vad vi fått rengöra ibland. Ingen nämnd ingen glömd i det fallet, 
men jag ska hålla fanan högt på det området medan du sitter på en veranda i 
68 
Skåne och klunkar Bandol. Yvonne, du håller gruppen och enheten i toppform 
genom en skön blandning av ledarskap och fredagsbubbel. Tack också för allt 
stöd runt tid och upplägg av detta projekt. Men din egen toppform påverkar en 
del medarbetare lite väl mycket. Håkan t.ex. Han tror på allvar att han kan nå 
låga 70kg… Crister, handledaren, mannen med väldigt många verktyg i sin 
låda. Jag tror tyskarna funderade ordentligt när du kom sent till det där 
telefonmötet för att du hade varit och gjort snö hela natten : ) Men för oss 
skidåkare en anledning så god som någon att vara sen till jobbet. Och lagar du 
inte bilen så bygger du väl om din Hi-Fi anläggning eller styckar en ren i 
garaget. Men till kaffet surrar jag hellre om vallor och strukturer än digital 
streaming, men det har du nog förstått vid det här laget. Men du har ett 
imponerande djup inom många fält även utanför kemin. Det skulle vara kul att 
följa med dig upp till Jokkmokk och jaga ihop dina renar någon gång, en 
upplevelse kan jag tänka mig. Calle, du lärde mig det mesta om bra och 
pålitliga data under din tid på FOI. Du har varit ett bra stöd genom detta arbete 
också. Ni andra ska veta att när man får kommentarer som ”jag är imponerad” 
från Calle, då känns det riktigt bra. Henrik, som redan tidigt såg mig som 
”FOIs nya påläggskalv”... Det tog ett tag, men nu blir jag granskad in på benet, 
så vi får se om jag blir pålägg eller köttfärs. Men vi har en hel del gemensamt. 
Fäblessen för tyska kvalitetsbilar bland annat. ”because the germans don’t 
know how to make bad cars”. Jag måste nog skaffa en Quattro® igen. 
Skidinstruktören Christian och cykelfixaren och stabile grannen Markus. 
Efterfesternas hedersmedlemmar: Oskar, Susanne, Lina, Ante m.fl. På den 
här festen får ni stanna så länge ni orkar. Och jag glömmer inte ölen och påsen 
med Polly i första taget, de satt bra! FUSK i alla dess former som inspirerar till 
träning på många olika sätt. Och Signar. Den som sett till att jag i alla fall 
tränat något under slutveckorna. Anders A och Fredrik för superb assistans i 
proteinstrukturernas värld.  Majken, Petra och ni andra som ger stöd när det 
som bäst behövs. Mats S som står bakom oss på många sätt. Mona, Johanna 
T, Lillemor, Rikard, Sofia & Bettan, och alla andra härliga FOI:ter, ingen 
nämnd ingen glömd, som gör stället så trevligt. 
Gunnar W, handledare och gisslan (som du själv uttryckte det). Men du 
har varit mycket mer än gisslan. Och du var den som en gång i tiden släppte 
fram mig till en Q-TOF för första gången. Tack för det också. Övriga SLU:are 
och UPSC folk: Hasse för ovärderliga strategiska tips inför skrivandet av 
kappan. Vi får paratas vid på festen huruvida det fungerade. Jocke, Jonas G, 
Maria A, Mr Moritz, tack för ert jobb och stöd på vägen fram. 
Tack till många utanför jobbet också. Till att börja med alla härliga vänner 
som jag/vi borde umgås mer med: De Umeå-nära Hanna&David, 
Emma&Peter, Karin&Micke, Erik&Maria, Anna&Jonas, Sandra&Frasse. 
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Öviksborna Mia&Johan, Mogge&Lina. Klintsjöborna Erik och Jonas med 
familjer. Knivstaborna Sara&Rune, stockholmarna Henke&Sofia, Ångeborna 
Malin&Kent. Jag passade även på att bjuda skidåkarna och gamla gänget på 
festen; Olof, Anders, Mats, Wangler, Johan S, David E med familjer. Får se 
om någon av dom har möjlighet att åter dyka upp i Umeå. Men visst borde vi ta 
oss iväg på lite mer skidåkning, grabbar? 
Och så några extra varma tack till de som står mig nära: Per&Carin och 
deras härliga grabbgäng i Täby, alltid lika kul att umgås med er. Jenny, det blir 
alltid trevligt när du är med. Ska du med till fjälls i år? Anita&S-G, 
omtänksamma, gästvänliga, hjälpsamma, och ett bra umgänge helt enkelt. Vårt 
stöd på distans när det behövs. Håkans, Bosses, Gun-Britt&Helge i Enånger, 
kusiner och kusinbarn. Morbror Seth. Micke&Jenny, alltid nära, alltid 
supportande. Viggo, Hilda och Sally, jag ska lära er köra det mesta och allt bus 
jag kan. Ni håller mig ung i pulkbacken. Johanna, du är mångas favorit, vi 
saknar dig härborta. Mamma, morsan, Gulli, farmor. Kärt barn har många 
namn. Du betyder väldigt mycket för mig och för oss alla tre. Tack för allt du 
gjort och allt du gör. Aldrig omöjlig, alltid govillesam. 
Alfred! Mitt stora driv här i livet. Min älskade grabb, min stolthet, kämpe 
och min bästa kompis. Nu börjar innebandysäsongen och det är dags att vi 
börjar träna in några finter. Jag ska t.ex. lära dig den enda dragning jag kan. 
Och så ska jag visa dig hur man skjuter för höga skott. Och så ska vi bygga 
klart din koja såklart. Förresten tror jag att det kan bli en liten crossmotorcykel 
för din del till våren. Det vore väl något? Men säg inget till mamma och 
mormor, då blir dom bara oroliga…    
Annika! Mitt fundament i livet. Tack för att du är min kärlek, bästa vän och 
största supporter på samma gång. Och dessutom min nära-till-hands kemiportal 
och figurproducent... I kemi är jag nöjd tvåa. 
Nu stundar bättre tider.  
